Elsevier’s ClinicalKey Now accelerates access to localised clinical guidelines and content for clinicians at the point of care

Elsevier, a global leader in evidence-based clinical practice content, research publishing and information analytics, today announces the launch of ClinicalKey Now, a mobile interactive discovery tool that enables clinicians in India to access accurate, concise, and actionable evidence-based information to support diagnosis and treatment of patients. Curated and peer-reviewed by expert physicians in India, the tool adheres to global practice standards while aligning with local and regional clinical guidelines. As a mobile-first tool, ClinicalKey Now facilitates physicians’ access to medical content with ease and convenience at the point of care.

One of the most pressing challenges in Indian healthcare is the unequal distribution of resources, highlighted by high patient-to-clinician ratios and limited access to quality healthcare. According to the World Health Organisation (WHO), the clinician-to-patient ratio in India is 1:1700 against the 1:1000 recommendation¹. This can put a strain on clinicians, who may have to spend a significant amount of time on administrative responsibilities. This can leave clinicians with little to no time to spend with their patients, which can then impact the quality of care that they are able to provide². To address these challenges, clinicians can leverage technology, such as ClinicalKey Now, to free up clinicians' time so that they can focus on providing care to their patients even in the remotest areas of the country.

ClinicalKey Now helps support physicians in the medical diagnosis and treatment process through its intuitive clinical algorithms, offering summarised practical steps for the management of patient conditions. It also contains a visual map that traces and maps symptoms to treatment methods. This intuitive user journey, all-optimised for a mobile experience, empowers physicians to find accurate answers within seconds, even when offline or in rural remote areas, in-between, or during patient consultations.

Shanker Kaul, Managing Director, India, Elsevier, said: “Due to the ever-increasing workload on medical practitioners, changing patient needs and barriers to accessing the latest verified information, physicians in India find it challenging to stay on top of advances in medicine. It is important for physicians to have access to tools that can help them to diagnose more accurately and prescribe more effective treatment plans that are in line with the Indian healthcare system, to manage common diseases and conditions within our population. ClinicalKey Now allows clinicians quick access to easily actionable and localised recommendations, reducing the time required for them to retrieve information to provide informed care to patients.”

ClinicalKey Now features longer form synoptic content inclusive of clinical reviews and offers comprehensive information and drug monographs, with coverage of approved combination therapies and availability of treatment in India. In addition, ClinicalKey Now provides concise answers through intuitive search to support physicians when diagnosing and treating patients ​wherever clinicians are practicing. This allows clinicians to spend more time supporting patients which in turn enables a streamlined workflow and helps improve the quality of care administered.

¹ Leveraging AI in the Indian healthcare system: Opportunities and challenges, Business Insider India, 30 June 2022

² Enabling healthcare with technology, PwC & BCC&I, March 2023

---

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야를 선도하는 글로벌 기업입니다. 100년 넘게 과학과 의료의 발전을 뒷받침하며 인류의 더 나은 미래를 위해 노력해왔습니다. 우리는 전 세계 170개국의 대학 및 기업 연구자, 의사, 간호사, 차세대 보건의료 인력과 교육자들이 중요한 업무를 수행할 수 있도록 지원하고 있습니다. 우리는 신뢰할 수 있는 근거 기반의 과학과 의학 콘텐츠에 첨단 인공지능(AI) 기술을 접목한 핵심 인사이트와 혁신적인 솔루션을 제공함으로써, 이들의 더 나은 성과 달성을 돕고자 합니다. 우리는 제품과 조직 문화 전반에 포용성과 지속 가능성의 가치를 반영하고, 함께하는 커뮤니티와의 협력을 통해 이를 실천해 나가고 있습니다. 엘스비어 재단(Elsevier Foundation)은 세계 곳곳에서 연구 및 보건 분야의 협력 사업을 후원하고 있습니다.

엘스비어는 전문가 및 비즈니스 고객을 위한 정보 기반 분석 및 의사결정 도구를 제공하는 글로벌 기업 RELX의 계열사입니다. 자세한 내용은 www.elsevier.com에서 확인하실 수 있으며, SNS @ElsevierConnect를 통해 최신 소식도 실시간으로 받아보실 수 있습니다.